Paul Daruwala

Title: Paul Daruwala: Innovator in Fungal Infection Treatments

Introduction

Paul Daruwala is a notable inventor based in Del Mar, California. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of fungal infections. With a total of 5 patents to his name, Daruwala's work is paving the way for innovative therapies.

Latest Patents

One of his latest patents focuses on "Compositions and methods for the treatment of fungal infections." This patent features non-irritating pharmaceutical compositions containing CD101 in a pharmaceutical acceptable salt or neutral form, such as CD101 acetate. These compositions can be intravenously administered to treat fungal infections, including candidiasis. Another significant patent is centered on "Dosing regimens for treatment of fungal infections," which includes pharmaceutical compositions, methods, and kits that feature dosing regimens involving CD101 or its acceptable forms.

Career Highlights

Daruwala is currently associated with Cidara Therapeutics, Inc., where he continues to develop innovative solutions for treating fungal infections. His expertise in pharmaceutical sciences has been instrumental in advancing the company's research and development efforts.

Collaborations

Some of his notable coworkers include Kenneth Bartizal and Voon Ong, who collaborate with him on various projects aimed at enhancing treatment options for patients suffering from fungal infections.

Conclusion

Paul Daruwala's contributions to the field of pharmaceutical compositions are significant, particularly in the treatment of fungal infections. His innovative patents and ongoing work at Cidara Therapeutics, Inc. highlight his commitment to improving patient outcomes.